Global /Italy /Healthcare /Medical Devices /DIA

DiaSorin S.p.A.

DIA

• MIL: DIA • Delayed

56.94EUR -1.7%

66.14 USD

As of 5 June 2026, DiaSorin S.p.A. has a market cap of $3.57B USD, ranking #4835 globally and #52 in Italy. It ranks #372 in the Healthcare sector, and #84 in the Medical Devices industry.

Global Rank

4835

Country Rank

Sector Rank

372

Industry Rank

Key Stats

Market Cap

$3.57BUSD

3.07B EUR

Enterprise Value

$4.23BUSD

3.64B EUR

Revenue (TTM)

$1.39BUSD

1.2B EUR

EBITDA (TTM)

$429.7MUSD

369.95M EUR

Net Income (TTM)

$180.76MUSD

155.62M EUR

EBITDA Margin

31%

Profit Margin

13%

PE Ratio

20.3

Forward PE

14.9

PS Ratio

2.6

PB Ratio

1.9

EV/EBITDA

9.5

Company Profile

Country (HQ)

Italy

Sector

Healthcare

Industry

Medical Devices

CEO

Carlo Rosa open_in_new

Employees

3,272

Founded

1968

Website

int.diasorin.com open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
-1.7%	-8.6%	-0.5%	-19%	-25%	-16%	-41%	-40%	-60%

News

Markets

Exchange	Ticker	Price	Quotes
Borsa Italiana (MIL / BIT) MIC: XMIL PRIMARY	DIA Diasorin SpA ISIN: IT0003492391 Shares Out.: Shares Outstanding: 53.001M¹ Shares Float: 20.734M² TV: TradingView: MIL: DIA SA: Stock Analysis: BIT: DIA YF: Yahoo Finance: DIA.MI GF: Google Finance: BIT: DIA BA: Barron's: DIA MS: Morningstar: XMIL: DIA	56.94 EUR	TV: TradingView: MIL: DIA SA: Stock Analysis: BIT: DIA YF: Yahoo Finance: DIA.MI GF: Google Finance: BIT: DIA BA: Barron's: DIA MS: Morningstar: XMIL: DIA
London Stock Exchange (LSE / LON) MIC: XLON	0GZX Diasorin SpA ISIN: IT0003492391 TV: TradingView: LSE: 0GZX SA: Stock Analysis: LON: 0GZX YF: Yahoo Finance: 0GZX.L GF: Google Finance: LON: 0GZX BA: Barron's: 0GZX MS: Morningstar: XLON: 0GZX	57.94 EUR	TV: TradingView: LSE: 0GZX SA: Stock Analysis: LON: 0GZX YF: Yahoo Finance: 0GZX.L GF: Google Finance: LON: 0GZX BA: Barron's: 0GZX MS: Morningstar: XLON: 0GZX
Frankfurt Stock Exchange (FRA) MIC: XFRA	34D Diasorin SpA ISIN: IT0003492391 TV: TradingView: FWB: 34D SA: Stock Analysis: FRA: 34D YF: Yahoo Finance: 34D.F GF: Google Finance: FRA: 34D BA: Barron's: 34D MS: Morningstar: XFRA: 34D	58.12 EUR	TV: TradingView: FWB: 34D SA: Stock Analysis: FRA: 34D YF: Yahoo Finance: 34D.F GF: Google Finance: FRA: 34D BA: Barron's: 34D MS: Morningstar: XFRA: 34D
Vienna Stock Exchange (VIE) MIC: XVIE	DIAS Diasorin SpA ISIN: IT0003492391 TV: TradingView: VIE: DIAS SA: Stock Analysis: VIE: DIAS YF: Yahoo Finance: DIAS.VI GF: Google Finance: VIE: DIAS BA: Barron's: DIAS MS: Morningstar: XVIE: DIAS	58.10 EUR	TV: TradingView: VIE: DIAS SA: Stock Analysis: VIE: DIAS YF: Yahoo Finance: DIAS.VI GF: Google Finance: VIE: DIAS BA: Barron's: DIAS MS: Morningstar: XVIE: DIAS
OTC Markets (OTCMKTS / OTC) MIC: OTCM	DSRLF Diasorin SpA ISIN: IT0003492391 Shares Out.: Shares Outstanding: 53.892M¹ Shares Float: 21.272M² TV: TradingView: OTC: DSRLF SA: Stock Analysis: OTC: DSRLF YF: Yahoo Finance: DSRLF GF: Google Finance: OTCMKTS: DSRLF BA: Barron's: DSRLF MS: Morningstar: PINX: DSRLF	107.68 USD	TV: TradingView: OTC: DSRLF SA: Stock Analysis: OTC: DSRLF YF: Yahoo Finance: DSRLF GF: Google Finance: OTCMKTS: DSRLF BA: Barron's: DSRLF MS: Morningstar: PINX: DSRLF

Show all 5 markets

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About DiaSorin S.p.A.

DiaSorin S.p.A. engages in research and development, manufacture, and distribution of immunodiagnostics and molecular diagnostics testing kits in Europe, North America, and internationally. It provides various immunodiagnostic in the areas, including infectious diseases, gastrointestinal diseases, hepatitis and retroviruses, endocrinology, metabolic disorders, tumor markers, and oncology under LIAISON XL and LIAISON XS name. The company also offers Simplexa, a congenital CMV direct kit, which detects cytomegalovirus DNA in saliva swab and urine specimens. In addition, it offers LIAISON PLEX Respiratory Flex Assay and the LIAISON PLEX Yeast Blood Culture Assay. Further, the company offers xMAP technology platform, including in vitro diagnostics. The company was founded in 1968 and is headquartered in Saluggia, Italy.

Similar Companies

Industry: Medical Devices (Italy)

Name	Market Cap (USD) diff.	PE	Country
Stevanato Group S.p.A. NYSE: STVN	$4.44B 24%	27.2	Italy
EL.En. S.p.A. MIL: ELN	$1.21B 1.05B EUR -66%	21.4	Italy
Safilo Group S.p.A. MIL: SFL	$804.96M 693.03M EUR -77%	14.4	Italy
Svas Biosana S.p.A. MIL: SVS	$55.92M 48.14M EUR -98%	7.1	Italy
I.M.D. International Medical Devices S.p.A. MIL: IMD	$28.57M 24.6M EUR -99%	17.6	Italy
Otofarma S.p.A. MIL: OTO	$27.01M 23.26M EUR -99%	-	Italy

Industry: Medical Devices (Global)

Name	Market Cap (USD) diff.	PE	Country
Thermo Fisher Scientific Inc. NYSE: TMO	$173.27B 5K%	25.8	United States
Intuitive Surgical, Inc. NASDAQ: ISRG	$160.73B 4K%	56.7	United States
Abbott Laboratories NYSE: ABT	$159.07B 4K%	25.6	United States
Danaher Corp. NYSE: DHR	$126.55B 3K%	34.7	United States
Stryker Corp. NYSE: SYK	$120.69B 3K%	38.3	United States
Medtronic plc NYSE: MDT	$101.9B 3K%	22.2	Ireland

chevron_leftBack